Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$7.56 - $16.15 $1.44 Million - $3.07 Million
190,000 New
190,000 $2.95 Million
Q2 2022

Aug 15, 2022

BUY
$20.49 - $39.72 $7.8 Million - $15.1 Million
380,513 Added 185.49%
585,654 $12.6 Million
Q1 2022

May 16, 2022

BUY
$28.19 - $46.6 $3.6 Million - $5.94 Million
127,528 Added 164.31%
205,141 $7.59 Million
Q4 2021

Feb 14, 2022

SELL
$41.2 - $73.6 $3.36 Million - $6 Million
-81,524 Reduced 51.23%
77,613 $3.53 Million
Q3 2021

Nov 15, 2021

SELL
$59.15 - $91.99 $938,296 - $1.46 Million
-15,863 Reduced 9.06%
159,137 $10.1 Million
Q2 2021

Aug 16, 2021

BUY
$63.02 - $95.11 $11 Million - $16.6 Million
175,000 New
175,000 $16 Million
Q4 2020

Feb 16, 2021

SELL
$41.43 - $77.09 $16.7 Million - $31 Million
-402,614 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$30.88 - $37.94 $963,733 - $1.18 Million
31,209 Added 8.4%
402,614 $15.3 Million
Q2 2020

Aug 14, 2020

SELL
$18.95 - $35.43 $128,594 - $240,427
-6,786 Reduced 1.79%
371,405 $13.2 Million
Q1 2020

May 15, 2020

SELL
$13.94 - $28.25 $2.69 Million - $5.46 Million
-193,143 Reduced 33.81%
378,191 $8.26 Million
Q4 2019

Feb 14, 2020

BUY
$19.24 - $28.41 $7.98 Million - $11.8 Million
414,618 Added 264.57%
571,334 $12.3 Million
Q3 2019

Nov 14, 2019

SELL
$20.03 - $40.08 $7.41 Million - $14.8 Million
-369,754 Reduced 70.23%
156,716 $3.54 Million
Q2 2019

Aug 14, 2019

BUY
$25.78 - $39.77 $6.88 Million - $10.6 Million
267,019 Added 102.92%
526,470 $18.9 Million
Q1 2019

May 14, 2019

BUY
$22.09 - $39.21 $5.73 Million - $10.2 Million
259,451 New
259,451 $8.18 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Intrinsic Edge Capital Management LLC Portfolio

Follow Intrinsic Edge Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrinsic Edge Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intrinsic Edge Capital Management LLC with notifications on news.